Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BECTON DICKINSON THYROID STIMULATING HORMONE SYSTE

K-Number: K925132 · 1992-12-28

ApplicantBecton Dickinson Advanced Diagnostics
Decision Date1992-12-28
Product CodeJLW
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

BECTON DICKINSON THYROID STIMULATING HORMONE SYSTE is the device name listed in this FDA 510(k) record. The listed applicant is Becton Dickinson Advanced Diagnostics. It received FDA 510(k) clearance on 1992-12-28 under 510(k) number K925132. The device is classified under product code JLW. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BECTON DICKINSON THYROID STIMULATING HORMONE SYSTE?

BECTON DICKINSON THYROID STIMULATING HORMONE SYSTE is a medical device that received FDA 510(k) clearance on 1992-12-28. The listed applicant is Becton Dickinson Advanced Diagnostics. The 510(k) number is K925132.

When did BECTON DICKINSON THYROID STIMULATING HORMONE SYSTE receive FDA 510(k) clearance?

BECTON DICKINSON THYROID STIMULATING HORMONE SYSTE received FDA 510(k) clearance on 1992-12-28, under 510(k) number K925132.

Who is the listed applicant for BECTON DICKINSON THYROID STIMULATING HORMONE SYSTE?

The FDA 510(k) record lists Becton Dickinson Advanced Diagnostics as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BECTON DICKINSON THYROID STIMULATING HORMONE SYSTE?

The FDA product code for BECTON DICKINSON THYROID STIMULATING HORMONE SYSTE is JLW.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Becton Dickinson Advanced Diagnostics as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K935667QTEST(R) STREPK931294IQ TUPTAKE ASSAYK931295IQ TT4 ASSAYK926356PRECISE(TM) HCG(URINE/SERUM) AND PRCISE(TM) PREGK923673PRECISE STREP AK923060IQ IMMUNOCHEMISTRY SISTEM; IQ TSH ASSAY

View all 10 devices →

Related Devices (Code: JLW)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K251543Atellica® IM TSH3-Ultra II (TSH3ULII)Siemens Healthcare Diagnostics, Inc.K243570Dimension LOCI Thyroid Stimulating Hormone Flex reagent cartridge (TSHL); Dimension LOCI Free Thyroxine Flex reagent cartridge (FT4L)Siemens Healthcare DiagnosticsK234091Maverick Diagnostic System TC1000; Maverick Test Panel A0.B0Genalyte, Inc.K233050ADVIA Centaur® TSH3-Ultra II (TSH3ULII)Siemens Healthcare Diagnostics, Inc.K222116Atellica® CI Analyzer, Atellica® IMThyroid Stimulating Hormone 3-Ultra (TSH3-UL), Atellica® CH Albumin BCP (AlbP)Siemens Healthcare Diagnostics, Inc.K221225Access TSH (3rd IS) Assay, DxI 9000 Access Immunoassay AnalyzerBeckman Coulter, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑